Scinovex
review Open AccessTop 1% cited

Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches

Molecules · 2022 · Vol. 27(17) · pp. 5730–5730
Mamello SekhoachaKeamogetswe RietPaballo MotloungLemohang GumenkuAyodeji Mathias AdegokeSamson S. Mashele

Abstract

Prostate cancer is one of the malignancies that affects men and significantly contributes to increased mortality rates in men globally. Patients affected with prostate cancer present with either a localized or advanced disease. In this review, we aim to provide a holistic overview of prostate cancer, including the diagnosis of the disease, mutations leading to the onset and progression of the disease, and treatment options. Prostate cancer diagnoses include a digital rectal examination, prostate-specific antigen analysis, and prostate biopsies. Mutations in certain genes are linked to the onset, progression, and metastasis of the cancer. Treatment for localized prostate cancer encompasses active surveillance, ablative radiotherapy, and radical prostatectomy. Men who relapse or present metastatic prostate cancer receive androgen deprivation therapy (ADT), salvage radiotherapy, and chemotherapy. Currently, available treatment options are more effective when used as combination therapy; however, despite available treatment options, prostate cancer remains to be incurable. There has been ongoing research on finding and identifying other treatment approaches such as the use of traditional medicine, the application of nanotechnologies, and gene therapy to combat prostate cancer, drug resistance, as well as to reduce the adverse effects that come with current treatment options. In this article, we summarize the genes involved in prostate cancer, available treatment options, and current research on alternative treatment options.

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentCancer, Lipids, and MetabolismProstate cancerMedicineProstatectomyOncologyRadiation therapyAndrogen deprivation therapyCancerDiseaseInternal medicineMetastasis

MeSH terms

Androgen AntagonistsHumansMaleNeoplasm Recurrence, LocalProstatectomyProstatic NeoplasmsSalvage TherapyProstate-Specific Antigen

Funding

  • National Research Foundation
Citations
801
FWCI
113.40
field-weighted impact
References
215
Percentile
100%
vs. same field & year
Citations per year
References
Estimates of cancer incidence and mortality in Europe in 2008
European Journal of Cancer · 2010 · 2,306 citations
EAU Guidelines on Prostate Cancer
European Urology · 2007 · 3,143 citations
Drug repurposing: progress, challenges and recommendations
Nature Reviews Drug Discovery · 2018 · 4,479 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.